Inogen (INGN) Shares Outstanding (Weighted Average) (2012 - 2026)
Inogen (INGN) reported Shares Outstanding (Weighted Average) of $27.3 million for Q1 2026, up 8.58% year-over-year from $25.2 million in Q1 2025, and up 2.71% on a QoQ basis from $26.6 million in Q4 2025.
Inogen (INGN) has 15 years of Shares Outstanding (Weighted Average) data on file, last reported at $27.3 million in Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 8.58% year-over-year to $27.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.3 million (up 8.58% YoY) and the FY2025 annual result came in at $26.6 million, up 12.46% from the prior year.
- Shares Outstanding (Weighted Average) improved to $27.3 million in Q1 2026 per INGN's latest filing, from $26.6 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $27.3 million in Q1 2026 and bottomed at $22.8 million in Q1 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $23.4 million (2024), against an average of $24.1 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) rose 1.02%; it then rose 12.46% in 2025.
- Tracing INGN's Shares Outstanding (Weighted Average) over 5 years: stood at $22.9 million in 2022, then grew by 1.42% to $23.2 million in 2023, then climbed by 2.06% to $23.7 million in 2024, then increased by 12.46% to $26.6 million in 2025, then climbed by 2.71% to $27.3 million in 2026.
- Per Business Quant, the three latest INGN Shares Outstanding (Weighted Average) figures stand at $27.3 million (Q1 2026), $26.6 million (Q4 2025), and $26.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 27.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.32 Mn |
| Dec 31, 2025 | 26.60 Mn |
| Sep 30, 2025 | 26.41 Mn |
| Jun 30, 2025 | 26.07 Mn |
| Mar 31, 2025 | 25.16 Mn |
| Dec 31, 2024 | 23.65 Mn |
| Sep 30, 2024 | 23.59 Mn |
| Jun 30, 2024 | 23.61 Mn |
| Mar 31, 2024 | 23.40 Mn |
| Dec 31, 2023 | 23.18 Mn |
| Sep 30, 2023 | 23.23 Mn |
| Jun 30, 2023 | 23.08 Mn |
| Mar 31, 2023 | 23.01 Mn |
| Dec 31, 2022 | 22.85 Mn |
| Sep 30, 2022 | 22.88 Mn |
| Jun 30, 2022 | 22.85 Mn |
| Mar 31, 2022 | 22.75 Mn |
| Dec 31, 2021 | 22.49 Mn |
| Sep 30, 2021 | 22.62 Mn |
| Jun 30, 2021 | 22.44 Mn |
| Mar 31, 2021 | 22.18 Mn |
| Dec 31, 2020 | 21.98 Mn |
| Sep 30, 2020 | 22.00 Mn |
| Jun 30, 2020 | 21.94 Mn |
| Mar 31, 2020 | 21.92 Mn |
| Dec 31, 2019 | 21.82 Mn |
| Sep 30, 2019 | 21.84 Mn |
| Jun 30, 2019 | 21.82 Mn |
| Mar 31, 2019 | 21.75 Mn |
| Dec 31, 2018 | 21.27 Mn |
| Sep 30, 2018 | 21.32 Mn |
| Jun 30, 2018 | 21.17 Mn |
| Mar 31, 2018 | 21.03 Mn |
| Dec 31, 2017 | 20.68 Mn |
| Sep 30, 2017 | 20.75 Mn |
| Jun 30, 2017 | 20.62 Mn |
| Mar 31, 2017 | 20.49 Mn |
| Dec 31, 2016 | 20.07 Mn |
| Sep 30, 2016 | 20.16 Mn |
| Jun 30, 2016 | 19.97 Mn |
| Mar 31, 2016 | 19.83 Mn |
| Dec 31, 2015 | 19.40 Mn |
| Sep 30, 2015 | 19.43 Mn |
| Jun 30, 2015 | 19.31 Mn |
| Mar 31, 2015 | 19.17 Mn |
| Dec 31, 2014 | 16.18 Mn |
| Sep 30, 2014 | 18.29 Mn |
| Jun 30, 2014 | 13.84 Mn |
| Mar 31, 2014 | 9.44 Mn |
| Dec 31, 2013 | 276,535.00 |
| Sep 30, 2013 | 274,357.00 |
| Jun 30, 2013 | 274,396.00 |
| Mar 31, 2013 | 272,226.00 |
| Dec 31, 2012 | 261,268.00 |